Last call for registrations to Pre-Filled Syringes East Coast conference

SMi Group8 - 9 April 2019, Boston, USA.
SMi's global portfolio of events on Pre-Filled Syringes secured an audience of over 300 senior drug delivery and medical device experts over the last year. Next week will be held the 6th annual Pre-Filled Syringes East Coast conference and exhibition where industry leaders from pharmaceutical, biotech and device manufacturing, meet to get updates on medical devices advances, parenteral drug delivery, share experiences and network. Organisers encourage everyone involved in the industry not to miss out on this premier platform as only limited number of delegate places remain. For those interested in attending, contact Kieran Ronaldson on +44 (0) 20 7827 6744 or book on the Pre-Filled Syringes East Coast conference website.

Event in brief: Over 25 presentations from a mix of leading industry players and big pharma such as - Shire, Merck, FDA, Janssen, Steri-Tek, Biogen, Sanofi, Eli Lilly, Zeon and many others.

Organisations who have recently secured some of the last few remaining places includeAmerican Regent, Credence MedSystems, Dechra, Imbrium Therapeutics, Nipro Pharma Packaging, Pfizer,Purdue Pharma, Plastic Ingenuity, Sumitomo Rubber North America, Uhlmann, W.L Gore. List of attendees available on the event website.

Over 15 exhibition stands will help navigate through supplier offers: 3P Innovation, Aptar Pharma, CSS (CONNECTICUT SPRING & STAMPING),HarroHöfliger, LONSTROFF, MITSUBISHI GAS CHEMICAL, NN Life Sciences, Owen Mumford, PHC Corporation of North America, Polyplastics, RheoSense, SCHOTT, Steri-Tek, SUMITOMO RUBBER INDUSTRIES, West Pharmaceutical Services and ZEON

To register for one of the last remaining delegate places, either call Kieran Ronaldson on +44 (0) 20 7827 6744 or book online at www.pfsamericas.com

About SMi Group

The SMi Group is a highly Professional, Independent and Global company that specialises in the production of Business-to-Business Conferences, Workshops and Masterclasses. We research, create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical sectors.

We believe in bringing you the best events incorporating:

  • In-depth analysis of the subject matter
  • Tools, techniques and information to immediately benefit your business
  • High level contact with expert speakers
  • Insight into new areas, refreshing your knowledge
  • Opportunities to learn from key opinion leaders, and to engage through Q&A
  • Sessions with leading professionals and to network before, during and after event

Our management team has more than 70 years collective experience in the conference industry and our long-term success has been established by providing a reliable and expert service. This gives you the delegate, the confidence and reassurance, in knowing that we have brought you the best speakers and content for 20 years. The SMi management team plays a very active role in the day to day running of the business and events and we look forward to meeting you at an event soon!

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...